lifesciencesipreview11h
Tissue repair VP gets new trial over secrets damages
Case concerns allegations that ex-senior vice president of business development at Skye Orthobiologics misappropriated ...
lifesciencesipreview11h
Labcorp's bid to invalidate Ravgen's DNA testing patent hits roadblock
Biotech walks away with another win as Fed Circ upholds PTAB decision | Labcorp’s attempt to overturn $373m verdict fails | ...
lifesciencesipreview12h
Troutman Pepper Locke exodus sees teams leave in Chicago and London
Two large teams leave Locke Lord following Troutman Pepper merger | Buchanan opens Chicago office with a large life sciences ...
lifesciencesipreview12h
Ex-Baker McKenzie patent litigation head joins Morgan Lewis in Germany
12 December 2024 Firm expands its Mechanical & Electromechanical Technologies Practice with latest addition | Partner brings ...
lifesciencesipreview5d
Mitsubishi Tanabe takes on Indian generic drugmaker’s ALS application
The Japanese pharma company files complaint against Lupin Pharmaceuticals | Suit alleges patent infringement over the company ...
lifesciencesipreview6d
Outlook for 2025: how Trump and the USPTO will affect life sciences IP
Key developments for the industry this year include a more pro-patent administration and USPTO changes, say Carla Ji-Eun Kim ...
lifesciencesipreview14d
Fed Circ orders Teva to delist five patents from Orange Book
18 June 2024 New Jersey court grants 30-day stay days after ordering the removal of five patents for asthma inhalers from FDA ...
lifesciencesipreview14d
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Massachusetts medical research company is awarded damages following a jury verdict that found a Japanese pharma had infringed on its patent | Patent relates to Duchenne muscular dystrophy treatment.